ID: ALA4114717

Max Phase: Preclinical

Molecular Formula: C32H41FN4O5

Molecular Weight: 580.70

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)C[C@H](NC(=O)[C@@H]1CCCN(C(=O)CCC2CCNCC2)C1)c1cncc(/C=C/c2cccc(OCCF)c2)c1

Standard InChI:  InChI=1S/C32H41FN4O5/c33-12-16-42-28-5-1-3-24(18-28)6-7-25-17-27(21-35-20-25)29(19-31(39)40)36-32(41)26-4-2-15-37(22-26)30(38)9-8-23-10-13-34-14-11-23/h1,3,5-7,17-18,20-21,23,26,29,34H,2,4,8-16,19,22H2,(H,36,41)(H,39,40)/b7-6+/t26-,29+/m1/s1

Standard InChI Key:  WQBFXJCREXXMOQ-KVGFIWLHSA-N

Associated Targets(Human)

Integrin alpha-IIb/beta-3 3481 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 580.70Molecular Weight (Monoisotopic): 580.3061AlogP: 4.25#Rotatable Bonds: 13
Polar Surface Area: 120.86Molecular Species: ZWITTERIONHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.83CX Basic pKa: 10.36CX LogP: -0.01CX LogD: -0.01
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.32Np Likeness Score: -0.92

References

1.  (2016)  Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombi, 

Source

Source(1):